U. Massafra

1.1k total citations
52 papers, 698 citations indexed

About

U. Massafra is a scholar working on Rheumatology, Surgery and Orthopedics and Sports Medicine. According to data from OpenAlex, U. Massafra has authored 52 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 15 papers in Surgery and 12 papers in Orthopedics and Sports Medicine. Recurrent topics in U. Massafra's work include Osteoarthritis Treatment and Mechanisms (17 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). U. Massafra is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (17 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). U. Massafra collaborates with scholars based in Italy, Lebanon and United States. U. Massafra's co-authors include Emanuele Bizzi, S. Tormenta, Alberto Migliore, Alberto Migliore, Andrea Alimonti, M Granata, Francesca Vacca, Serena Broccoli, Prisco Piscitelli and Bruno Frediani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Osteoarthritis and Cartilage.

In The Last Decade

U. Massafra

50 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Massafra Italy 18 420 281 194 99 61 52 698
Adrian Pendleton United Kingdom 9 260 0.6× 270 1.0× 113 0.6× 85 0.9× 21 0.3× 18 631
Beatrice Hanslik‐Schnabel Austria 10 293 0.7× 297 1.1× 146 0.8× 63 0.6× 23 0.4× 12 695
Wing‐Yee Kwok Netherlands 17 863 2.1× 340 1.2× 136 0.7× 273 2.8× 34 0.6× 36 1.0k
Masanori Wako Japan 17 113 0.3× 427 1.5× 137 0.7× 73 0.7× 111 1.8× 53 843
W.F. Lems Netherlands 12 342 0.8× 104 0.4× 94 0.5× 39 0.4× 41 0.7× 38 486
Κ. Abendroth Germany 13 226 0.5× 135 0.5× 164 0.8× 16 0.2× 111 1.8× 44 559
E Vignon France 11 364 0.9× 156 0.6× 53 0.3× 105 1.1× 17 0.3× 40 461
Paola Frallonardo Italy 16 475 1.1× 110 0.4× 64 0.3× 83 0.8× 17 0.3× 39 653
Ryota Takatori Japan 13 119 0.3× 181 0.6× 140 0.7× 73 0.7× 153 2.5× 36 500
Jean‐Hugues Salmon France 12 268 0.6× 160 0.6× 43 0.2× 68 0.7× 22 0.4× 43 501

Countries citing papers authored by U. Massafra

Since Specialization
Citations

This map shows the geographic impact of U. Massafra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Massafra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Massafra more than expected).

Fields of papers citing papers by U. Massafra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Massafra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Massafra. The network helps show where U. Massafra may publish in the future.

Co-authorship network of co-authors of U. Massafra

This figure shows the co-authorship network connecting the top 25 collaborators of U. Massafra. A scholar is included among the top collaborators of U. Massafra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Massafra. U. Massafra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gori, Francesca, Massimo Mammucari, Alberto Migliore, et al.. (2022). Intradermal therapy (mesotherapy): the lower the better. Cineca Institutional Research Information System (Tor Vergata University). 7 indexed citations
2.
Mammucari, Massimo, Teresa Paolucci, Domenico Russo, et al.. (2021). A Call to Action by the Italian Mesotherapy Society on Scientific Research. Drug Design Development and Therapy. Volume 15. 3041–3047. 8 indexed citations
3.
Petruccioli, Elisa, Linda Petrone, Teresa Chiacchio, et al.. (2021). Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease. Frontiers in Immunology. 12. 716857–716857. 10 indexed citations
4.
Massafra, U., et al.. (2020). A review of network meta-analysis comparing biologics in the treatment of rheumatoid arthritis.. SHILAP Revista de lepidopterología. 24(4). 1624–1644. 3 indexed citations
5.
Chiacchio, Teresa, Elisa Petruccioli, Valentina Vanini, et al.. (2019). Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases. Journal of Infection. 79(1). 15–23. 18 indexed citations
6.
8.
Massafra, U., et al.. (2015). Mixed Treatment Comparison to Rank Antiresorptive Agents In Preventing New Non Vertebral Fractures In Postmenopausal Osteoporosis. Value in Health. 18(7). A636–A636. 4 indexed citations
10.
Bizzi, Emanuele, U. Massafra, Bruno Laganà, et al.. (2014). Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review. Clinical Rheumatology. 33(7). 877–884. 3 indexed citations
11.
Migliore, Alberto, U. Massafra, Emanuele Bizzi, et al.. (2013). Delay of Total Hip Replacement (THR) Using HA Viscosupplementation: Is Cost Effective?. Value in Health. 16(7). A562–A562. 1 indexed citations
12.
Migliore, Alberto, Serena Broccoli, U. Massafra, Emanuele Bizzi, & Bruno Frediani. (2012). Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis. Current Medical Research and Opinion. 28(3). 467–473. 17 indexed citations
13.
Tormenta, S., Luca Maria Sconfienza, Emanuele Bizzi, et al.. (2012). Prevalence Study of Iliopsoas Bursitis in a Cohort of 860 Patients Affected by Symptomatic Hip Osteoarthritis. Ultrasound in Medicine & Biology. 38(8). 1352–1356. 19 indexed citations
14.
Migliore, Alberto, et al.. (2011). Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip. Reumatismo. 56(2). 104–9. 5 indexed citations
16.
Migliore, Alberto, Emanuele Bizzi, U. Massafra, et al.. (2010). Can Cyclosporine-A Associated to Methotrexate Maintain Remission Induced by Anti-TNF Agents in Rheumatoid Arthritis Patients? (Cynar Pilot Study). International Journal of Immunopathology and Pharmacology. 23(3). 783–790. 6 indexed citations
17.
Migliore, Alberto, U. Massafra, Emanuele Bizzi, et al.. (2009). Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix®) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Research & Therapy. 11(6). R183–R183. 59 indexed citations
18.
Zoli, Angelo, et al.. (2006). Osteoporosis and bone metabolism in postmenopausal women with osteoarthritis of the hand. Menopause The Journal of The North American Menopause Society. 13(3). 462–466. 31 indexed citations
19.
Migliore, Alberto, et al.. (2005). The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clinical Rheumatology. 25(3). 389–393. 47 indexed citations
20.
Migliore, Alberto, et al.. (2004). Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clinical Rheumatology. 24(3). 285–289. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026